DEL GIACCO, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 251.907
NA - Nord America 11.081
AS - Asia 2.203
SA - Sud America 49
AF - Africa 45
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 5
Totale 265.313
Nazione #
IT - Italia 248.483
US - Stati Uniti d'America 10.988
CN - Cina 1.253
UA - Ucraina 1.213
SE - Svezia 724
SG - Singapore 529
DE - Germania 402
FI - Finlandia 355
GB - Regno Unito 275
VN - Vietnam 152
FR - Francia 132
CA - Canada 82
NL - Olanda 59
KR - Corea 52
HK - Hong Kong 43
BE - Belgio 39
TR - Turchia 38
ES - Italia 34
IN - India 33
RU - Federazione Russa 29
BR - Brasile 27
IE - Irlanda 27
IR - Iran 22
AU - Australia 18
RO - Romania 18
ID - Indonesia 15
AT - Austria 13
BY - Bielorussia 10
CZ - Repubblica Ceca 10
IL - Israele 10
JP - Giappone 10
PT - Portogallo 10
CO - Colombia 9
MA - Marocco 9
ZA - Sudafrica 9
CH - Svizzera 8
MX - Messico 8
MY - Malesia 8
RS - Serbia 8
TW - Taiwan 8
CI - Costa d'Avorio 7
LT - Lituania 7
MK - Macedonia 7
BG - Bulgaria 6
PH - Filippine 6
CL - Cile 5
DK - Danimarca 5
EU - Europa 5
HU - Ungheria 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
UZ - Uzbekistan 5
LU - Lussemburgo 4
NG - Nigeria 4
SI - Slovenia 4
EG - Egitto 3
GR - Grecia 3
HR - Croazia 3
KE - Kenya 3
PE - Perù 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
EC - Ecuador 2
IQ - Iraq 2
KW - Kuwait 2
LV - Lettonia 2
LY - Libia 2
PL - Polonia 2
SD - Sudan 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
Totale 265.313
Città #
Cagliari 240.122
Uta 6.625
Fairfield 1.334
Woodbridge 1.041
Chandler 987
Boardman 865
Houston 793
Ashburn 682
Jacksonville 644
Wilmington 581
Nyköping 524
Ann Arbor 501
Seattle 449
Cambridge 409
Singapore 246
Nanjing 199
Boston 183
Helsinki 174
Shanghai 172
Dearborn 170
Beijing 165
Santa Clara 154
Dong Ket 150
Milan 127
Rome 118
San Diego 108
Redwood City 84
Guangzhou 67
Nanchang 67
New York 65
Los Angeles 60
Toronto 60
Shenyang 56
Jiaxing 52
Changsha 48
Hebei 48
Verona 41
London 39
Sassari 39
Mountain View 38
Hong Kong 37
Norwalk 37
Tianjin 37
Orange 35
Brussels 34
Seoul 33
Florence 31
Auburn Hills 28
Redmond 28
Washington 27
Monserrato 22
Phoenix 22
Zhengzhou 22
Jinan 21
Ningbo 21
Turin 20
Amsterdam 19
Falls Church 19
Bologna 18
Kocaeli 18
Salerno 18
Hefei 16
Hangzhou 15
Bari 14
Chicago 14
Dublin 14
Genoa 14
Munich 14
Borås 13
Naples 13
Padova 13
Wuhan 13
Palermo 12
Sestu 12
Vicenza 12
Paris 11
Quartu Sant'Elena 11
Vienna 11
Brescia 10
Frankfurt am Main 10
Jakarta 10
San Mateo 10
Taizhou 10
Wuxi 10
Pune 9
Shenzhen 9
Atlanta 8
Augusta 8
Gyeongsan-si 8
Leawood 8
Quartu Sant'elena 8
Rozzano 8
Abidjan 7
Bogazici 7
Cosenza 7
Hounslow 7
Jinhua 7
Kunming 7
Monmouth Junction 7
Napoli 7
Totale 259.238
Nome #
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 20.525
Overexpression of the cytokine BAFF and autoimmunity risk 3.907
TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome 3.891
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 3.755
The salivary proteome profile in patients affected by SAPHO syndrome characterized by a top-down RP-HPLC-ESI-MS platform 3.721
The asthma-anxiety connection 3.621
Systemic lupus erythematosus occurring in a patient with Niemann-Pick type B disease. 3.405
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.363
Proteomic analysis of the acid-insoluble fraction of whole saliva in subjects affected by Angioedema 3.282
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management 3.119
The Salivary Proteome Profile in Patients Affected by SAPHO Syndrome characterized by a top-down RP-HPLC-ESI-MS platform 2.888
Vaping effects on asthma: results from a web survey and clinical investigation 2.816
Characterization of patients with angioedema without wheals: The importance of F12 gene screening 2.640
Fungal allergy in asthma 2.619
Proteomic Analysis of the Acid-Insoluble Fraction of Whole Saliva from Patients Affected by Different Forms of Non-histaminergic Angioedema 2.616
Exercise-induced anaphylaxis with an Ayurvedic drug as cofactor: A case report 2.609
Alteration of the salivary secretory proteome profile in adults affected by antibody deficiency diseases 2.607
SAPHO Syndrome: Current developments and approaches to clinical treatment 2.583
Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis 2.537
COVID-19 in the mediterranean area: Epidemiology and main disease characteristics - A narrative review 2.534
RP-HPLC-ESI-IT Mass Spectrometry Reveals Significant Variations of the Human Salivary Protein Profile Associated with Predominantly Antibody Deficiencies 2.495
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 2.431
Biological treatments for SAPHO syndrome: an update 2.344
Impaired endothelial function in hereditary angioedema during the symptom-free period 2.294
Evaluation of olfactory function as a potential biomarker in patients with Mastocytosis 2.275
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 2.199
Oxidative stress markers in patients with hereditary angioedema 2.187
Baricitinib exposure during pregnancy in rheumatoid arthritis 2.172
Alteration of the Salivary Secretory Proteome Profile in Adults Affected by Immune Deficiency Diseases 2.156
Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie = Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic 2.111
Increased peripheral T(H)17 Cells in SAPHO syndrome: a novel target for treatment? 2.103
Biologics for ANCA-associated vasculitis 2.098
Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study 2.023
An uncommon cause of refractory pleural effusion in an elderly patient 1.914
Clinical pitfalls of leishmaniasis and Whipple’s disease hidden behind systemic lupus erythematosus: A case series 1.891
Periodic fever syndromes and autoinflammatory diseases: a case series from an Italian centre 1.890
The role of genetics in the current diagnostic workup of idiopathic non-histaminergic angioedema 1.847
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 1.831
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.829
Unravelling the genetics of complex diseases through random forest: Application to genome wide association of Asthma in a genetic isolate of Ogliastra 1.807
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather? 1.781
Mutation of angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema 1.731
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma 1.691
Asthma and psychiatric disorders 1.683
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 1.652
The climate in the European Union and the enlarged European Region is a determinant of the COVID-19 case fatality ratio 1.571
Influenza burden, prevention and treatment in asthma - a scoping review by the EAACI Influenza in Asthma Task Force 1.528
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.512
Exercise and asthma: an overview 1.508
EAACI Biologicals Guidelines—Recommendations for severe asthma 1.503
Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery 1.500
Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency: a case report 1.475
A strategy analysis for genetic association studies with known inbreeding 1.450
Is hereditary angioedema related to an increased risk of atherosclerosis? 1.441
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma 1.426
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype 1.416
Management of Intermittent and Persistent Asthma in Adolescent and High School Athletes 1.399
Hyperosinophilia and recurrent angioedema in a patient with giant cell arteritis: a diagnostic "glitch" in a case of Gleich's syndrome 1.388
The COVID-19 incidence in Italian regions correlates with low temperature, mobility and PM10 pollution but lethality only with low temperature 1.378
A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout 1.360
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 1.322
Celiac disease: peripheral blood cell-mediated response to antigen-specific stimulation 1.314
Biologics for SAPHO syndrome: a single centre experience 1.300
New drugs in early-stage clinical trials for allergic rhinitis 1.282
Exercise training, lymphocyte subsets and their cytokines production: experience of an Italian professional football team and their impact on allergy 1.281
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.268
Allergy in severe asthma 1.261
Eosinophilic granulomatosis with polyangiitis relapse after covid-19 vaccination: A case report 1.230
Feasibility of the Allergy Questionnaire for Athletes (AQUA©) in pediatric age 1.229
Asthma and dietary intake: an overview of systematic reviews 1.228
Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms 1.224
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 1.219
Exercise, Asthma and the Olympics: A 2000-year-old tale 1.215
Prioritising research challenges and funding for allergy and asthma and the need for translational research - The European Strategic Forum on Allergic Diseases 1.194
Aerobic exercise training reduces bronchial hyper-responsiveness and serum pro-inflammatory cytokines in patients with asthma 1.177
Playing with trees in a genome wide association study 1.176
A Traditional Diet Is Associated with a Reduced Risk of Eczema and Wheeze in Colombian Children 1.171
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination 1.170
Towards clinically applicable biomarkers for asthma - An EAACI position paper 1.169
Urticaria and angioedema as possible misleading skin symptoms in families with hereditary angioedema 1.157
An uncommon association of antiphospholipid syndrome, selective IgA deficiency and resistant-to-treatment relapsing polychondritis: efficacy of Infliximab 1.157
Melkersson-Rosenthal Syndrome: A case report 1.150
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor 1.140
Severe asthma: entering an era of new concepts and emerging therapies: Highlights of the 4th International Severe Asthma Forum, Madrid, 2018 1.139
An application of Random Forest and Hungarian Method to genome wide association of asthma in a genetic isolate of Ogliastra 1.132
Dietary intake and risk of asthma in children and adults: protocol for a systematic review and meta-analysis 1.128
Pathophysiological mechanisms of exercise-induced anaphylaxis: an EAACI position statement 1.109
COVID-19 Case Fatality Ratio of Latino America Countries with Temperate Climate Partially Follows European and Oceania Trends According to Seasonal Change 1.091
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma 1.088
Idiopathic pyoderma gangrenosum: Successful resolution with Infliximab therapy and proinflammatory cytokines assessment 1.077
Olfactory Function Is Impaired in Patients with Mastocytosis 1.068
Angioedema without wheals: a retrospective analysis of a single center cohort 1.065
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor 1.059
Raynaud's phenomenon and scleroderma associated with silicone gel breast implants: An example of Asia syndrome 1.046
Oxidative stress in hereditary angioedema caused by C1 inhibitor deficiency: An interesting finding that deserves further studies 1.001
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 987
Adult antibody deficiency syndrome and Henoch-Schoenlein Purpura: a report of two cases 970
Asthma, allergy and the olympics: A 12-year survey in elite athletes 941
Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: A case report 926
Changes in symptoms of asthma and rhinitis by sensitization status over ten years in a cohort of young Chilean adults 916
Totale 197.105
Categoria #
all - tutte 346.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 346.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028.473 0 0 0 0 11.394 7.986 4.486 1.138 710 756 686 1.317
2020/202154.752 1.590 1.844 1.923 13.310 10.848 6.356 4.781 3.832 1.744 3.077 3.198 2.249
2021/202215.372 1.534 940 766 1.246 1.264 1.183 847 765 1.581 1.285 1.974 1.987
2022/202322.245 1.824 2.679 2.741 1.695 1.861 2.218 1.096 2.977 1.350 1.246 1.600 958
2023/202427.804 1.698 1.079 1.332 2.184 2.634 4.326 4.137 2.416 1.517 1.857 2.322 2.302
2024/202568.073 15.068 34.717 9.350 5.674 3.264 0 0 0 0 0 0 0
Totale 266.268